1
H and 13 C NMR spectra were recorded using a Bruker Avance 400 spectrometer; chemical shifts (δ) are reported in parts per million (ppm) relative to TMS as internal standard. Mass spectra were recorded using Waters/Micromass GC-TOF (low-and high-resolution) and Applied Biosystems/MDS Sciex QSTAR XL QTOF (low-resolution) instruments in electron ionization (EI) mode. Differential scanning calorimetry (DSC) analyses were performed using a TA Instruments Q2000 instrument with a scanning rate of 3 K min -1 , unless otherwise noted. Texture analyses were performed using a Nikon Eclipse E600 POL polarized microscope fitted with a Linkam LTS 350 hot stage and TMS 93 temperature controller. Optical tilt angles were measured as a function of temperature by polarized microscopy as half the rotation between the two extinction positions corresponding to opposite signs of an applied electric field of 2 V μm -1 using the chiral dopant 2-(4-(11-(1,1,1,3,3,5,5-heptamethyltrisiloxanyl)undecyloxy)phenyl)-5-((2R,3R)-difluorooctyloxy)pyrimidine (1-2 mol%). 1 The mixtures were introduced into ITO glass cells with a rubbed Nylon alignment layer (5 μm spacing, 0.25 cm 2 addressed area, AWAT PPW, Poland), and aligned by slow cooling from the isotropic phase to the chiral SmC* phase at 2 K min -1 while applying a 6 V μm -1 triangular wave ac field. Small angle X-ray scattering data from unaligned samples (filled into Mark capillary tubes of 0.7 mm diameter) were obtained using a Kratky compact camera (A. Paar) equipped with a temperature controller (A. Paar) and a one-dimensional electronic detector (M.Braun). All chemicals were obtained from commercial sources under otherwise noted. 4-Methoxybenzohydrazide (8) was purchased from Alfa Aesar. 4-(Methoxymethoxy)phenylboronic acid, 2 3-chloro-6-iodopyridazine (4), 3 11-(1,1,1,3,3,5,5-heptamethyltrisiloxanyl)undecanol, 4 and 9-chlorononanoyl chloride 5, 6 were prepared according to literature procedures and shown to have the expected physical and spectral properties. a 4-(Methoxymethoxy)phenylboronic acid, Pd 2 (dba) 3 3-Chloro-6-(4-(methoxymethoxy)phenyl)pyridazine (5). A 50 mL Schlenk flask was charged with 4 (0.73 g, 3.0 mmol), 4-(methoxymethoxy)phenylboronic acid (0.70 g, 3.9 mmol), Pd 2 (dba) 3 (27.6 mg, 0.030 mmol) and Cy 3 P (20.1 mg, 0.072 mmol), then evacuated and filled with argon (5×). Degassed dioxane (15 mL) and aq K 3 PO 4 (1.27 M, 4.0 mL, 5.08 mmol) were added by syringe, the Schlenk flask was sealed and heated in an oil bath at 100 °C for 18 h with vigorous stirring. The mixture was then filtered through a pad of silica gel and washed with EtOAc. The filtrate was concentrated and the aqueous residue extracted three times with EtOAc. The combined extracts were dried (MgSO 4 ), concentrated, and the residue purified by flash chromatography on silica gel (20% EtOAc/hexanes) to give 5 (0.52 g, 70%) as a white 
3-(7-Chloroheptyloxy)-6-(4-(methoxymethoxy)phenyl)pyridazine (6).
A mixture of 7-chloro-1-heptanol (0.60 g, 4 mmol) and NaH (60% oil suspension, 0.16 g, 4 mmol) in dry THF (10 mL) was stirred for 1 hour, and a suspension of 5 (0.25 g, 1.0 mmol) in dry THF (20 mL) was added in one portion. The mixture was stirred overnight at room temperature and then slowly quenched with sat aq NH 4 Cl. The mixture was poured into H 2 O (30 mL) and extracted with CH 2 Cl 2 (100 mL, then 3 × 10 mL). The combined extracts were washed with brine, dried (MgSO 4 ), concentrated, and the residue was purified by flash chromatography on silica gel (25% EtOAc/hexanes) to give 6 (0.22 g, 60%) as a white solid: mp 82-83 °C; 
3-(7-Chloroheptyloxy)-6-(4-hydroxyphenyl)pyridazine (7).
To a solution of 6 (0.2 g, 0.55 mmol) in isopropanol (20 mL) was added 6 M aq HCl (0.5 mL, 3.0 mmol). After stirring for 5 hours at 50 °C, the solution was concentrated and diluted with CH 2 Cl 2 (20 mL) and H 2 O (20 mL). The layers were separated and the aqueous layer was extracted with CH 2 Cl 2 (3 × 10 mL). The combined extracts were dried (MgSO 4 ), concentrated, and the residue was purified by flash chromatography on silica gel (33% EtOAc/hexanes) to give 7 (0.16 g, 91%) as a white solid: mp 102-103 °C; 1 (11-(1,1,1,3,3 N'-(9-Chlorononanoyl)-4-methoxybenzohydrazide (9). 9-Chlorononanoyl chloride was added dropwise to a solution of 4-methoxybenzohydrazide (1.4 g, 8.1 mmol) and Na 2 CO 3 (3.4 g) in CH 2 Cl 2 (60 mL) at 0 °C. The reaction mixture was stirred for 1h, and then allowed to warm to room temperature. After 18 hours, the mixture was filtered and the solid residue washed with CH 2 Cl 2 (100 mL) and EtOAc (100 mL). The filtrate was concentrated and the residue was purified by flash chromatography on silica gel (3:1 CH 2 Cl 2 /EtOAc) to give 9 (1.2 g, 52%) as a white solid: mp 107-109 °C; 
3-(7-Chloroheptyloxy)-6-(4-

2-(8-Chlorooctyl)-5-(4-methoxyphenyl)-1,3,4-thiadiazole (10).
A mixture of 9 (1.1 g, 3.2 mmol) and Lawesson reagent (1.5 g, 3.7 mmol) in toluene (80 mL) was heated to reflux and stirred for 2 h under a nitrogen atmosphere. After cooling to room temperature, the mixture was poured into water (60 mL) and extracted with CHCl 3 (3×30 mL). The combined extracts were washed with water, dried (MgSO 4 ), concentrated, and the crude product was purified by flash chromatography on silica gel (9:1 CH 2 Cl 2 /EtOAc) to give 10 (0.65 g, 60%) as a white solid: mp 70-71 °C; 
